Live from the NIH registry
Studies recruiting near Salt Lake City right now
Top 25 of 1,155 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Utah Cancer Specialists-Salt Lake City — Salt Lake City, Utah (2.4 mi)
· Sponsor: SWOG Cancer Research Network
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Primary Children's Hospital — Salt Lake City, Utah (2.4 mi)
· Sponsor: National Cancer Institute (NCI)
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
Intermountain Medical Center ( Site 0182) — Murray, Utah (8.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Salt Lake City, Utah (2.4 mi)
· Sponsor: Sameek Roychowdhury
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Huntsman Cancer Institute, University of Utah — Salt Lake City, Utah (2.4 mi)
· Sponsor: Relay Therapeutics, Inc.
Developing an Innovative Decision Support Tool for Pediatric Neuromuscular Scoliosis
Children With Medical Complexity (CMC), Multiple Chronic Conditions
N/A
Interventional 110 participants sought
University of Utah — Salt Lake City, Utah (2.4 mi)
· Sponsor: University of Utah
ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection
Clostridium Difficile Infection Recurrence
Phase 2
Interventional 20 participants sought
University of Utah — Salt Lake City, Utah (2.4 mi)
· Sponsor: Acurx Pharmaceuticals Inc.
NETs: Protection or Harm in Neonatal Inflammation or Infection
Necrotizing Enterocolitis (NEC)
N/A
Observational 388 participants sought
University of Utah — Salt Lake City, Utah (2.4 mi)
· Sponsor: University of Utah
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Utah Cancer Specialists-Salt Lake City — Salt Lake City, Utah (2.4 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Retina Associates of Utah, PLLC — Salt Lake City, Utah (2.4 mi)
· Sponsor: Genentech, Inc.
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Heart Failure
Phase 3
Interventional 1,500 participants sought
CON-10305, Layton, UT — Layton, Utah (19.6 mi)
· Sponsor: Colorado Prevention Center
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Chronic Migraine
Phase 3
Interventional 420 participants sought
Highland Clinical Research /ID# 270281 — Salt Lake City, Utah (2.4 mi)
· Sponsor: AbbVie
Progestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window Trial
Endometrial Endometrioid Adenocarcinoma, Endometrial Hyperplasia
Phase 2
Interventional 140 participants sought
University of Utah Sugarhouse Health Center — Salt Lake City, Utah (2.4 mi)
· Sponsor: New Mexico Cancer Research Alliance
Precision Genomics Medicine Biobank
Any Disease Condition and Reportedly-healthy Subjects
N/A
Observational 100,000 participants sought
Intermountain Healthcare — Murray, Utah (8.0 mi)
· Sponsor: Intermountain Health Care, Inc.
Effect of Sleep Extension on Ceramides in People with Overweight and Obesity
Lifestyle Factors, Overweight and Obesity
N/A
Interventional 70 participants sought
College of Health Research Complex--University of Utah — Salt Lake City, Utah (2.4 mi)
· Sponsor: University of Utah
Shortened Course of Radiation Therapy After Trans-oral Robotic Surgery in Patients With HPV-Mediated Oropharyngeal Squamous Cell Carcinoma.
Oropharyngeal Squamous Cell Carcinoma, HPV-mediated Oropharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 42 participants sought
Huntsman Cancer Institute/University of Utah — Salt Lake City, Utah (2.4 mi)
· Sponsor: University of Utah
A Multi-Site Feasibility Trial of Embedded Emergency Department Physical Therapy
Low Back Pain
N/A
Interventional 140 participants sought
University of Utah — Salt Lake City, Utah (2.4 mi)
· Sponsor: Northwestern University
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Intracerebral Hemorrhage
Phase 3
Interventional 350 participants sought
University of Utah Healthcare — Salt Lake City, Utah (2.4 mi)
· Sponsor: Joseph Broderick, MD
Healing ALS Registry Observational Study (HAROS)
Amyotrophic Lateral Sclerosis (ALS), Motor Neuron Disease (MND)
N/A
Observational 1,000 participants sought
Virtual — Park City, Utah (24.4 mi)
· Sponsor: Healing Advocates Registry and Ministry
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
Graves Disease
Phase 3
Interventional 300 participants sought
Site-013 — Layton, Utah (19.6 mi)
· Sponsor: Biohaven Therapeutics Ltd.
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Bladder Carcinoma, Ureter Carcinoma
N/A
Observational 2,020 participants sought
Utah Cancer Specialists — Salt Lake City, Utah (2.4 mi)
· Sponsor: Guardant Health, Inc.
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
Asthma
Phase 3
Interventional 440 participants sought
Research Site — West Jordan, Utah (11.6 mi)
· Sponsor: AstraZeneca
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
Squamous Cell Carcinoma of Head and Neck
Phase 1, Phase 2
Interventional 287 participants sought
University of Utah Huntsman Cancer Institute — Salt Lake City, Utah (2.4 mi)
· Sponsor: Janssen Research & Development, LLC
A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)
Ovarian Cancer Recurrent
Phase 1, Phase 2
Interventional 460 participants sought
START Mountain Region ( Site 0008) — West Valley City, Utah (7.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
Efficacy and Safety of 4F-PCC (4-Factor Prothrombin Complex Concentrate) in Adult Patients Undergoing Complex Cardiovascular Surgery With Cardiopulmonary Bypass (CPB)
Complex Cardiovascular Surgery With Cardiopulmonary Bypass
Phase 3
Interventional 200 participants sought
University of Utah — Salt Lake City, Utah (2.4 mi)
· Sponsor: CSL Behring